Dmitri Simberg

5.9k total citations · 1 hit paper
100 papers, 4.6k citations indexed

About

Dmitri Simberg is a scholar working on Biomaterials, Immunology and Molecular Biology. According to data from OpenAlex, Dmitri Simberg has authored 100 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Biomaterials, 39 papers in Immunology and 29 papers in Molecular Biology. Recurrent topics in Dmitri Simberg's work include Nanoparticle-Based Drug Delivery (40 papers), Complement system in diseases (29 papers) and RNA Interference and Gene Delivery (20 papers). Dmitri Simberg is often cited by papers focused on Nanoparticle-Based Drug Delivery (40 papers), Complement system in diseases (29 papers) and RNA Interference and Gene Delivery (20 papers). Dmitri Simberg collaborates with scholars based in United States, United Kingdom and Denmark. Dmitri Simberg's co-authors include S. Moein Moghimi, Priya Karmali, Yechezkel Barenholz, Guankui Wang, Erkki Ruoslahti, Nirmal K. Banda, Yeshayahu Talmon, Linping Wu, Michael J. Sailor and V. Michael Holers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Dmitri Simberg

93 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo

2016 455 citations Guankui Wang, James I. Griffin et al. Nature Nanotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dmitri Simberg United States	34	2.1k	1.9k	1.6k	928	658	100	4.6k
Julie Audet Canada	18	2.4k 1.2×	1.9k 1.0×	2.9k 1.9×	564 0.6×	761 1.2×	47	5.3k
Julia Y. Ljubimova United States	38	2.0k 1.0×	2.1k 1.1×	1.6k 1.0×	312 0.3×	474 0.7×	83	5.0k
Richard Tsai United States	18	1.7k 0.8×	1.3k 0.7×	1.3k 0.8×	766 0.8×	674 1.0×	41	4.1k
William C. Zamboni United States	46	3.1k 1.5×	3.3k 1.7×	2.4k 1.6×	626 0.7×	579 0.9×	202	8.0k
G. Storm Netherlands	42	2.5k 1.2×	2.8k 1.4×	1.5k 1.0×	685 0.7×	519 0.8×	137	6.2k
Gianfranco Pasut Italy	36	2.7k 1.3×	3.2k 1.6×	1.4k 0.9×	417 0.4×	520 0.8×	109	7.1k
Kenneth A. Howard Denmark	42	1.6k 0.8×	4.3k 2.3×	1.5k 1.0×	520 0.6×	652 1.0×	108	6.8k
Masayuki Yokoyama Japan	42	2.5k 1.2×	1.4k 0.7×	1.1k 0.7×	603 0.6×	674 1.0×	141	5.5k
Zhuo Chen China	31	2.4k 1.1×	3.3k 1.7×	1.8k 1.2×	420 0.5×	724 1.1×	80	6.5k
Roberto Molinaro United States	29	1.4k 0.7×	1.6k 0.9×	1.4k 0.9×	698 0.8×	402 0.6×	49	3.6k

Countries citing papers authored by Dmitri Simberg

Since Specialization

Citations

This map shows the geographic impact of Dmitri Simberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitri Simberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitri Simberg more than expected).

Fields of papers citing papers by Dmitri Simberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitri Simberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitri Simberg. The network helps show where Dmitri Simberg may publish in the future.

Co-authorship network of co-authors of Dmitri Simberg

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitri Simberg. A scholar is included among the top collaborators of Dmitri Simberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitri Simberg. Dmitri Simberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feng, Yutian, Truc T. Huynh, David Siegel, et al.. (2025). Longitudinal Imaging Reveals Tumor Uptake and Prolonged Retention of Bispecific T Cell–Engaging Antibody in GBM via Passive and Active Mechanisms. Clinical Cancer Research. 31(16). 3537–3549.

Moghimi, S. Moein & Dmitri Simberg. (2025). Nanomedicine–lipoprotein interactions. Nature Reviews Bioengineering. 3(6). 435–437. 3 indexed citations

Rosa, Francisco G. La, Larry W. Moreland, Luigi Nibali, et al.. (2025). Pathotype-Specific Expression of Granzyme-Perforin Pathway Genes and Their Association With Clinical Disease Activity in Early Rheumatoid Arthritis and in a Randomized Clinical Trial. Immune Network. 25(4). e25–e25.

Gaikwad, Hanmant, Nirmal K. Banda, V. Michael Holers, et al.. (2025). Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors. Science Advances. 11(28). eadw1731–eadw1731. 1 indexed citations

Li, Yue, Laura Saba, Robert I. Scheinman, et al.. (2024). Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts. ACS Nano. 18(42). 28649–28658. 9 indexed citations

Li, Yue, Hanmant Gaikwad, Andrew A. Monte, et al.. (2024). Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin. Molecular Pharmaceutics. 21(6). 3053–3060. 8 indexed citations

Simberg, Dmitri & S. Moein Moghimi. (2024). Anti-Poly(ethylene glycol) (PEG) Antibodies: From Where Are We Coming and Where Are We Going. SHILAP Revista de lepidopterología. 5(3). 99–103. 3 indexed citations

Holers, V. Michael, Rachel M. Frank, Michael J. Zuscik, et al.. (2024). Decay-Accelerating Factor Differentially Associates With Complement-Mediated Damage in Synovium After Meniscus Tear as Compared to Anterior Cruciate Ligament Injury. Immune Network. 24(2). e17–e17. 2 indexed citations

Simberg, Dmitri, Hanmant Gaikwad, David Siegel, et al.. (2023). Cyanine lipids promote the shedding of extracellular vesicles from cell membranes. SHILAP Revista de lepidopterología. 6(3). 1 indexed citations

10.

Li, Yue, Hanmant Gaikwad, Guankui Wang, et al.. (2023). Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins. Nature Nanotechnology. 19(2). 246–254. 26 indexed citations

11.

Gaikwad, Hanmant, Yue Li, Guankui Wang, et al.. (2022). Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on “Pseudovirus-like” Nanoparticles. ACS Nano. 16(6). 8704–8715. 8 indexed citations

12.

Wu, Linping, Mario Ficker, Jørn B. Christensen, et al.. (2021). Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking. Nature Communications. 12(1). 4858–4858. 27 indexed citations

13.

Wang, Guankui, Hanmant Gaikwad, Mary K. McCarthy, et al.. (2021). Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro. SHILAP Revista de lepidopterología. 4(1). 724–737. 18 indexed citations

14.

Moghimi, S. Moein, Dmitri Simberg, Tore Skotland, Anan Yaghmur, & A. Christy Hunter. (2019). The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses. Journal of Pharmacology and Experimental Therapeutics. 370(3). 581–592. 52 indexed citations

15.

Vu, Vivian, Fangfang Chen, Guankui Wang, et al.. (2018). Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles. Nature Nanotechnology. 14(3). 260–268. 243 indexed citations

16.

Moghimi, S. Moein & Dmitri Simberg. (2018). Nanoparticle transport pathways into tumors. Journal of Nanoparticle Research. 20(6). 169–169. 46 indexed citations

17.

Tavano, Regina, Luca Gabrielli, Elisa Lubian, et al.. (2018). C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes. ACS Nano. 12(6). 5834–5847. 106 indexed citations

18.

Griffin, James I., Guankui Wang, Vivian Vu, et al.. (2017). Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy. ACS Nano. 11(11). 11584–11593. 29 indexed citations

19.

Griffin, James I., Michael J. Benchimol, & Dmitri Simberg. (2017). Longitudinal monitoring of skin accumulation of nanocarriers and biologicals with fiber optic near infrared fluorescence spectroscopy (FONIRS). Journal of Controlled Release. 247. 167–174. 10 indexed citations

20.

Shi, Guixin, Rajesh Mukthavaram, Santosh Kesari, & Dmitri Simberg. (2013). Distearoyl Anchor‐Painted Erythrocytes with Prolonged Ligand Retention and Circulation Properties In Vivo. Advanced Healthcare Materials. 3(1). 142–148. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact